Sandrine Marréaud

19.5k citations
145 papers · 7.7k indexed · 7 hit papers · h-index 38
Topics
Sarcoma Diagnosis and Treatment (55 papers)Vascular Tumors and Angiosarcomas (31 papers)Lung Cancer Treatments and Mutations (16 papers)
Partner nations
BelgiumFranceNetherlands

In The Last Decade

Sandrine Marréaud

143 papers receiving 7.6k citations

Hit Papers

Doxorubicin alone versus intensified doxorubicin plus ifo...200920262014202020142010200920112012250500750

Peers

Sandrine Marréaud
Comparison fields: 5 of 110
  • Pulmonary and Respiratory Medicine 4.8k
  • Oncology 3.8k
  • Surgery 2.7k
  • Molecular Biology 1.6k
  • Cardiology and Cardiovascular Medicine 1.3k
Replace Saul E. Rivkin with:
Saul E. Rivkin United States
D. Spooner United Kingdom
Jonathan E. Rosenberg United States
Werner Hohenberger Germany
Aristotelis Bamias Greece
Jae‐Lyun Lee South Korea
Muhyi Al‐Sarraf United States
Jürgen Dunst Germany
Denis Soulières Canada
Shenhong Wu United States
Sandrine Marréaud relative to Saul E. Rivkin United States Saul E. Rivkin's profile →
Citations per field
00.5×9.6×
Saul E. Rivkin · 1×
Citations per year

Countries citing papers authored by Sandrine Marréaud

Since Specialization
Citations

This map shows the geographic impact of Sandrine Marréaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandrine Marréaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandrine Marréaud more than expected).

Fields of papers citing papers by Sandrine Marréaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandrine Marréaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandrine Marréaud. The network helps show where Sandrine Marréaud may publish in the future.

Co-authorship network of co-authors of Sandrine Marréaud

This figure shows the co-authorship network connecting the top 25 collaborators of Sandrine Marréaud. A scholar is included among the top collaborators of Sandrine Marréaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandrine Marréaud. Sandrine Marréaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 7
3 1
4 10
5 7
6 2
7 32
8 94
9 2
10 0
11 59
12 10
13 41
14 118
15 244
16 47
17 324
18 37
19
Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)breakdown →
535
20 123

About Sandrine Marréaud

Sandrine Marréaud is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Gastroenterology, having authored 145 papers that have together received 7.7k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (55 papers), Vascular Tumors and Angiosarcomas (31 papers) and Lung Cancer Treatments and Mutations (16 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.8k citations), Oncology (3.8k citations) and Surgery (2.7k citations). Sandrine Marréaud has collaborated with scholars based in Belgium, France and Netherlands. Frequent co-authors include Sandra Collette, Jean‐Yves Blay, Richard Sylvester, Jaap Verweij, Patrick Schöffski, Peter Hohenberger, Saskia Litière, J. Martijn Kerst, Ian Judson and Winette T.A. van der Graaf. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026